Denied health claims on blood pressure reduction
European Union
May 18, 2022
Commission Regulation (EU) 2022/727 of 11 May 2022 refusing to authorise a health claim made on foods and referring to the reduction of disease risk
Rejected health claim
Application – Relevant provisions of Regulation (EC) No 1924/2006 |
Nutrient, substance, food or food category |
Claim |
EFSA opinion reference |
Article 14(1)(a) health claim referring to a reduction of a disease risk. |
‘Symbiosal®’ (a food supplement containing sea salt (97 %) plus chitosan (3 %)). |
‘Symbiosal®’ has been shown to lower the rising of blood pressure when used as a replacement of traditional table salt. The rising of blood pressure is a risk factor for high blood pressure (hypertension). |
Q-2018-00002 |
For further information (in English), click on the Link